Alterations of HLA class I and II antigen expression in preinvasive, invasive and metastatic cervical cancers

Experimental and Molecular Medicine

Volumn 33, Issue 3, 2001, Pages 136-144

  Ryu, Ki Sung ^a   Soo, Youn Lee ^b   Kim, Byung Kee ^b   Park, Yong Gyu ^b   Kim, Yong Wook ^a   Hur, Soo Young ^a   Kim, Tae Eung ^a   Kim, In Kyung ^b   Kim, Jin Woo ^a,b  

^a The Catholic University of Korea   (South Korea)

^b The Catholic University of Korea   (South Korea)

Author keywords

Cervical cancer; HLA class I; HLA class II; IHS; Metastasis

Indexed keywords

BETA 2 MICROGLOBULIN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HLA B ANTIGEN; HLA C ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; CANCER GROWTH; CONTROLLED STUDY; FEMALE; HLA SYSTEM; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INVASIVE CARCINOMA; MAJOR CLINICAL STUDY; METASTASIS; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU;

EID: 0035975569     PISSN: 12263613     EISSN: 20926413     Source Type: Journal    
DOI: 10.1038/emm.2001.24     Document Type: Article

References (7)

1. Browning M, Dunnion D. HLA and cancer: implications for cancer immunotherapy and vaccination. Eur J Immunogenet 1997;24:293-312
2. Campbell RD, Trowsdale J. Map of the human MHC. Immunol Today 1993;14:349-52
3. Cromme FV, Meijer CJ, Snijders PJ, Uyterlinde A, Kenemaris P, Heimerhorst T, Stern PL, van den Brule AJ, Walboomers JM. Analysis of MHC class I and II expression in relation to presence of HPV genotypes in premalignant and malignant cervical lesions. Br J Cancer 1993a;67:1372-80
4. Cromme FV, Snijders PJ, van den Brule AJ, Kenemans P, Meijer CJ, Walboomers JM. MHC class I expression in HPV 16 positive cervical carcinomas is post-transcriptionally controlled and independent from c-myc overexpression. Oncogene 1993b;8:2969-75
5. Cromme FV, Airey J, Heemels MT, Ploegh HL, Keating PJ, Stern PL, Meijer CJ, Walboomers JM. Loss of transporter protein, encoded by the TAP-1 gene, is highly correlated with loss of HLA expression in cervical carcinomas. J Exp Med 1994a;179:335-40
6. Cromme FV, van Bommel PF, Walboomers JM, Gallee MP, Stern PL, Kenemans P, Helmerhorst TJ, Stukart MJ, Meijer CJ. Differences in MHC and TAP-1 expression in cervical cancer lymph node metastases as compared with the primary tumours. Br J Cancer 1994b;69:1176-81
7. Garrido F, Cabrera T, Lopez-Nevot MA, Ruiz-Cabello F. HLA class I antigens in human tumors. Adv Cancer Res 1995;67:155-95